| Treatment Guidelines and the Interface with Prevention |  | 
|  |
| Comprehensive Guideline Summary |  | 
|  |
| Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents |  | 
|  |
| What the Guidelines Address |  | 
|  |
| Websites to Access the Guidelines |  | 
|  |
| Tools to Achieve Treatment Goals |  | 
|  |
| Use of HIV RNA Levels to Guide Therapy Decisions |  | 
|  |
| Potential Benefits of Early Therapy |  | 
|  |
| Potential Benefits of Early Therapy |  | 
|  |
| Potential Benefits of Early Therapy |  | 
|  |
| Potential Limitations of Early Therapy |  | 
|  |
| Recommendations for Initiating ART |  | 
|  |
| Recommendations for Initiating ART |  | 
|  |
| Recommendations for Initiating ART |  | 
|  |
| Consider More Rapid Initiation of ART |  | 
|  |
| Four Prevention Opportunities |  | 
|  |
| ART to Prevent Sexual Transmission of HIV |  | 
|  |
| HIV Infection Rates in the Tenofovir and Placebo Gel Groups: Kaplan-Meier Survival Probability |  | 
|  |
| Current and Proposed Systemic PrEP Trials |  | 
|  |
| Four Prevention Opportunities |  | 
|  |
| HPTN 052 Prevention Results |  | 
|  |
| HPTN 052 Clinical Results |  | 
|  |
| When to Start Therapy: Balance Has Tipped Further in Favor of Earlier Initiation |  | 
|  |
| Relative Time on Treatment... |  | 
|  |
| Relative Time on Treatment... |  | 
|  |
|
 |